Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) ("Cipher" or "the Company") today announced it has strengthened its product pipeline by acquiring the worldwide rights to three products from Astion ...
MISSISSAUGA, ON, Jan. 8, 2018 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) today announced the Canadian launch of OZANEX ™ (ozenoxacin cream, 1%), a novel bactericidal topical antibiotic cream ...
Please provide your email address to receive an email when new articles are posted on . Cipher Pharmaceuticals announced it has acquired three products from Astion Pharma that are focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results